CCTG has opened the anticipated international brain cancer study CCTG CE9 (LUMOS2) - joining forces with the Australian Cooperative Trials Group for Neuro-Oncology (COGNO) to make enrollment accessible to Canadian patients.
MRD Driven Study of Venetoclax + Chemotherapy for Newly Diagnosed Younger Patients with Intermediate Risk AML
Novel Therapeutics in Younger Patients with High-Risk AML (MM1YA-S01)
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer
CTDNA Response Adaptive Immuno-Chemotherapy in Non-Small Cell Lung Cancer
The CCTG ES3 NEEDS international esophageal cancer clinical trial is now opened in Canada. The study is investigating whether delaying surgery for patients with squamous cell carcinoma of the esophagus is as good as the current treatment.
Eradicating MRD in patients with AML prior to Stem Cell Transplant (ERASE)
Radiotherapy to Block (CURB2) Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
SLIDE-HCC: Phase II trial of STRIDE (durvalumab + tremelimumab) + lenvatinib vs STRIDE in patients with unresectable hepatocellular carcinoma
CALMS: Combination Therapy with Luspatercept in Lower Risk MDS CTEP approval: 2024AUG27 (date of US Steering Committee Evaluation)
Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Docetaxel and Hormone Treatment compared to Hormone Treatment alone in people with Metastatic Castration Sensitive Prostate Cancer and Less than Optimal PSA Response (TRIPLE-SWITCH)
CCTG GI disease site committee says thank you to Dr Breadner for his contribution to the CO.29 study as a new investigator by accruing a patient to a GIDSC trial for the first time, in November 2021.
For 2021/2022 holiday season CCTG will operate with limited coverage on the following dates:
A widely used and inexpensive Type 2 diabetes drug, once hoped to hold enormous promise in treating breast cancer, does not prevent or stop the spread of the most common forms of the disease, according to new findings.
The San Antonio Breast Cancer Symposium (December 7-10, 2021) is currently underway at the Gonzalez Convention Center in San Antonio, Texas and online.The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.
Where and when to see CCTG studies at SABCS 2021:
ASH 2021 is and important gathering of scientist interested in malignant and non-malignant hematology. This year the event will be held at the Georgia World Congress Center in Atlanta, Georgia or virtually from December 11-14, 2021, where they present the newest advances in hematology.
Here is a list of the CCTG studies at ASH next week.
The CommNETs Annual Research Workshop will be held virtually via Zoom November 30th to December 2nd (Canada) and December 1st to 3rd (Australia and New Zealand).
